Absence of peroxisome proliferators-activated receptors (PPAR) α enhanced the multiple organ failure induced by zymosan

Shock

Volumn 26, Issue 5, 2006, Pages 477-484

  Di Paola, Rosanna ^a   Esposito, Emanuela ^b   Mazzon, Emanuela ^a,c   Genovese, Tiziana ^a,c   Muià, Carmelo ^a   Crisafulli, Concetta ^a   Malleo, Giuseppe ^a   Sessa, Edoardo ^c   Meli, Rosaria ^b   Cuzzocrea, Salvatore ^a,c  

^a UNIVERSITY OF MESSINA   (Italy)

^b IRCCS CENTRO NEUROLESI BONINO PULEJO   (Italy)

^c UNIVERSITY OF NAPLES FEDERICO II   (Italy)

Author keywords

Inflammation; Multiple organ failure; PPAR ; Shock; Systemic inflammation; Zymosan

Indexed keywords

3 NITROTYROSINE; FAS LIGAND; MYELOPEROXIDASE; NITRATE; NITRITE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; TUMOR NECROSIS FACTOR ALPHA; ZYMOSAN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; INFLAMMATION; INTESTINE INJURY; KIDNEY INJURY; LIPID PEROXIDATION; LIVER INJURY; MORTALITY; MOUSE; MULTIPLE ORGAN FAILURE; NEUTROPHIL CHEMOTAXIS; NONHUMAN; PANCREAS INJURY; PATHOPHYSIOLOGY; PERITONITIS; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; TISSUE INJURY;

ANIMALS; APOPTOSIS; FAS LIGAND PROTEIN; INFLAMMATION; INTESTINES; KIDNEY; LIPID PEROXIDATION; MICE; MICE, KNOCKOUT; MULTIPLE ORGAN FAILURE; NEUTROPHIL INFILTRATION; NITRIC OXIDE; PPAR ALPHA; SHOCK; TUMOR NECROSIS FACTOR-ALPHA; TYROSINE; UP-REGULATION; ZYMOSAN;

EID: 33750282283     PISSN: 10732322     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.shk.0000230299.78515.2c     Document Type: Article

References (36)

1. Members of the American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference Committee. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Crit Care Med 20:864-874, 1992.
2. Baue AE, Durham R, Faist E: Systemic inflammatory response syndrome (SIRS), multiple organ dysfunction syndrome (MODS), multiple organ failure (MOF): are we winning the battle? Shock 10:79-89, 1998.
3. Volman TJ, Goris RJ, van der Jagt M, van de Loo FA, Hendriks T: Organ damage in zymosan-induced multiple organ dysfunction syndrome in mice is not mediated by inducible nitric oxide synthase. Crit Care Med 30:1553-1559, 2002.
4. Deitch EA, Ma L, Berg RD, Specian RD: Protein malnutrition predisposes to inflammatory-induced gut-origin septic states. Ann Surg 221:560-568, 1990.
5. Cuzzocrea S, Mazzon E, Dugo L, Barbera A, Centorrino T, Ciccolo A, Fonti MT, Caputi AP: Inducible nitric oxide synthase knock out mice exhibit a resistance to multiple organ failure induced by zymosan. Shock 16:51-58, 2001.
6. Kolaczkowska E, Shahzidi S, Seljelid R, van Rooijen N, Plytycz B: Early vascular permeability in murine experimental peritonitis is co-mediated by resident peritoneal macrophages and mast cells: crucial involvement of macrophage-derived cysteinyl-leukotrienes. Inflammation 26:61-71, 2002.
7. Moras D, Gronemeyer H: The nuclear receptor ligand-binding domain: structure and function. Curr Opin Cell Biol 10:384-391, 1998.
8. Murphy GJ, Holder JC: PPAR-gamma agonists: therapeutic role in diabetes, inflammation and cancer. Trends Pharmacol Sci 21:469-474, 2000.
9. Wayman NS, McDonald MC, Threadgill MD, Thiemermann C: 5-Amino isoquinolinone, a potent inhibitor of poly (adenosine 5′-diphosphate ribose) polymerase, reduces myocardial infarct size. Eur J Pharmacol 430:93-100, 2001.
10. Escher P, Braissant O, Basu-Modak S, Michalik L, Wahli W, Desvergne B: Rat PPARs: quantitative analysis in adult rat tissues and regulation in fasting and refeeding. Endocrinology 142:4195-4202, 2001.
11. Sher T, Yi HF, McBride OW, Gonzalez FJ: cDNA cloning, chromosomal mapping, and functional characterization of the human peroxisome proliferator activated receptor. Biochemistry 32:5598-5604, 1993.
12. Lovett-Racke AE, Hussain RZ, Northrop S, et al.: Peroxisome proliferator-activated receptor alpha agonists as therapy for autoimmune disease. J Immunol 172(9):5790-5798, 2004.
13. Staels B, Koenig W, Habib A, et al: Activation of human aortic smooth muscle cells is inhibited by PPARα but not by PPARγ activators. Nature 393:790-793, 1998.
14. Genovese T, Mazzon E, Di Paola R, Cannavo G, Muia C, Bramanti P, Cuzzocrea S: Role of endogenous ligands for the peroxisome proliferators activated receptors alpha in the secondary damage in experimental spinal cord trauma. Exp Neurol 194:267-278, 2005.
15. Muià C, Mazzon E, Crisafulli C, Di Paola R, Genovese T, Caputi AP, Cuzzocrea S: Role of endogenous peroxisome proliferator-activated receptor-alpha (PPAR-alpha) ligands in the development of gut ischemia and reperfusion in mice. Shock 25:17-22, 2006.
16. Mullane KM, Kraemer R, Smith B: Myeloperoxidase activity as a quantitative assessment of neutrophil infiltration into ischemic myocardium. J Pharmacol Methods 14:157-167, 1985.
17. Ohkawa H, Ohishi N, Yagi K: Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem 95:351-358, 1979.
18. Clark RB: The role of PPARs in inflammation and immunity. J Leukoc Biol 71:388-400, 2002.
19. Peters JM, Hennuyer N, Staels B, Fruchart JC, Fievet C, Gonzales FJ, Auwerx J: Alterations in lipoprotein metabolism in peroxisome proliferator-activated receptor α-deficient mice. J Biol Chem 272:27307-27312, 1997.
20. Aoyama T, Peters JM, Iritani N, Nakajima T, Furihata K, Hashimoto T, Gonzalez FJ: Altered constitutive expression of fatty acid-metabolizing enzymes in mice lacking the peroxisome proliferator receptor α. J Biol Chem 273:5678-5684, 1998.
21. Devchand PR, Keller H, Peters JM, Vasquez M, Gonzales FJ, Wahli W: The PPARα-leukotriene B4 pathway to inflammation control. Nature 384:39-43, 1996.
22. Kleemann R, Gervois PP, Verschuren L, Staels B, Princen HM, Kooistra T: Fibrates down-regulate IL-1-stimulated C-reactive protein gene expression in hepatocytes by reducing nuclear p50-NFκB-C/EBP-β complex formation. Blood 101:545-551, 2003.
23. Gervois P, Vu-Dac N, Kleemann R, Kockx M, Dubois G, Laine B, Kosykh V, Fruchart JC, Kooistra T, Staels B: Negative regulation of human fibrinogen gene expression by peroxisome proliferator-activated receptor alpha agonists via inhibition of CCAAT box/enhancer-binding protein beta. J Biol Chem 276:33471-33477, 2001.
24. Sharma K, Wang RX, Zhang LY, Yin DL, Luo XY, Solomon JC, Jiang RF, Markos K, Davidson W, Scott DW, et al: Death the Fas way: regulation and pathophysiology of CD95 and its ligand. Pharmacol Ther 88:333-347, 2000.
25. Dosreis GA, Borges VM, Zin WA: The central role of Fas-ligand cell signaling in inflammatory lung diseases. J Cell Mol Med 8:285-293, 2004.
26. Bauer MK, Vogt M, Los M, Siegel J, Wesselborg S, Schulze-Osthoffm K: Role of reactive oxygen intermediates in activation-induced CD95 (APO-1/Fas) ligand expression. J Biol Chem 273:8048-8055, 1998.
27. Cuzzocrea S, Zingarelli B, Sautebin L, et al: Multiple organ failure following zymosan-induced peritonitis is mediated by nitric oxide. Shock 4:268-275, 1997.
28. Hohlbaum AM, Gregory MS, Ju ST, Marshak-Rothstein A: Fas ligand engagement of resident peritoneal macrophages in vivo induces apoptosis and the production of neutrophil chemotactic factors. J Immunol 167:6217-6224, 2001.
29. Zanotti S, Kumar A, Kumar A: Cytokine modulation in sepsis and septic shock. Expert Opin Investig Drugs 11:1061-1075, 2002.
30. Hill MR, Clarke S, Rodgers K, Thornhill B, Peters JM, Gonzalez FJ, Gimble JM: Effect of peroxisome proliferator-activated receptor alpha activators on tumor necrosis factor expression in mice during endotoxemia. Infect Immun 67:3488-3493, 1999.
31. Cuzzocrea S, Costantino G, Mazzon E, Caputi AP: Protective effect of N-acetylcysteine on multiple organ failure induced by zymosan in the rat. Crit Care Med 27:1524-1532, 1999.
32. Cuzzocrea S, Di Paola R, Mazzon E, Genovese T, Muia C, Centorrino T, Caputi AP: Role of endogenous and exogenous ligands for the peroxisome proliferators activated receptors alpha (PPAR-alpha) in the development of inflammatory bowel disease in mice. Lab Invest 84:1643-1654, 2004.
33. Lee H, Shi W, Tontonoz P, Wang S, Subbanagounder G, Hedrick CC, Hama S, Borromeo C, Evans RM, Berliner JA, et al: Role for peroxisome proliferator-activated receptor α in oxidized phospholipid-induced synthesis of monocyte chemotactic protein-1 and interleukin-8 by endothelial cells. Circ Res 87:516-521, 2000.
34. Marzocco S, Di Paola R, Genovese T, Sorrentino R, Britti D, Scollo G, Pinto A, Cuzzocrea S, Autore G: Methylguanidine reduces the development of non septic shock induced by zymosan in mice. Life Sci 75:1417-1433, 2004.
35. Szabó C, Lim LH, Cuzzocrea S: Inhibition of poly (ADP-ribose) synthetase attenuates neutrophil recruitment and exerts anti-inflammatory effects. J Exp Med 186:1041-1049, 1997.
36. Cuzzocrea S, Zingarelli B, Caputi AP: Role of peroxynitrite and poly (ADP-ribosyl) synthetase activation in cardiovascular derangement induced by zymosan in the rat. Life Sci 63:923-933, 1999.